United StatesCarbamazepine Tablets, USP 200 mg in 1000-count bottles (NDC 51407-215-10) and 100-count bottles (NDC 51407-215-01), marketed by GSMS, Inc. and manufactured by Taro Pharmaceutical Industries Ltd., lot numbers GS067429, GS068091 (1000‑count) and GS067430, GS068090 (100‑count), expiring 5/31/2028, are being recalled nationwide in the U.S. The recall was initiated for CGMP deviations after tablets were found with black specks.
What's being recalled
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Recalling firm: Golden State Medical Supply Inc., Camarillo, CA, United States.
How to identify it
Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
The hazard
CGMP deviations: tablets with black specks.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
USA Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)